Finland· FI-REL-REL7890

Telepaque

A iopanoic acid product, registered in Finland by Sanofi-Winthrop Production Division. The same ATC class is registered in 2 of our 19 countries.

ATC V08AC06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedTelepaqueATCV08AC06REGISTER NO.FI-REL-REL7890PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Iopanoic acid is registered in 2 of 19 countries.

Countries holding a registration under ATC V08AC06 (iopanoic acid), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Iopanoic acid · ATC V08AC06

2 / 19 countries

  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Manufacturer
Sanofi-Winthrop Production Division
Country
Finland (FI)
ATC code
V08AC06
ATC class
Iopanoic acid
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

42 interactions on record for iopanoic acid.

Graded by severity as the source publishes them — 41 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Iopanoic acid · interactions on record

42 records

  • 41 moderate
  • 1 minor

Most severe, free to view

  • PindololC07AA03moderate
  • PropranololC07AA05moderate
  • TimololC07AA06moderate
  • SotalolC07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b81fb1ba-22b4-47bb-80be-dae427edca29
GET /v1/drugs/b81fb1ba-22b4-47bb-80be-dae427edca29?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "tabletti",
  "route": null,
  "ddd_unit": null,
  "strength": "500 mg",
  "atc_label": "jopanoiinihappo",
  "ma_number": "3653",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL7890",
  "authorised_at": "1966-06-22"
}

See everything about iopanoic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.